氯氮平配合酒精在小鼠体内 协同作用的研究

Study on the Synergistic Interaction between Clozapine and Alcohol in Mice

摘要: 目的：建立小鼠血液中氯氮平的LC-MS/MS分析方法，研究不同酒精饮料(啤酒、果酒、白酒)与氯氮平联合使用时在小鼠体内的药代动力学特征。方法：30只KM小鼠随机分为无酒对照组、啤酒协同组、果酒协同组和白酒协同组。各组灌胃给予相应溶剂配制的氯氮平溶液后，于12个时间点采集血样。血样经乙腈沉淀蛋白处理后，采用LC-MS/MS进行分析。色谱柱为Thermo Hypersil GOLD C18 (2.1 mm × 100 mm, 1.9 µm)，以0.1%甲酸水溶液和乙腈为流动相进行梯度洗脱，质谱采用ESI正离子MRM模式检测。结果：所建方法线性良好(R² = 0.9979)，检出限(LOD)和定量限(LOQ)分别为0.02 ng/mL和0.1 ng/mL。药时曲线表明，氯氮平达峰时间(Tmax)约为0.5~1小时。与无酒组相比，各酒精协同组显著提高了氯氮平的血药浓度峰值(Cmax)，且酒精浓度越高，增效作用越明显(白酒组 > 果酒组 > 啤酒组)，酒精协同还延缓了氯氮平的代谢清除。行为学观察显示，酒精协同使小鼠中毒症状(痉挛、昏迷)出现时间提前，昏迷持续时间延长。结论：酒精能通过抑制代谢酶等方式，显著增强氯氮平的生物利用度并延长其作用时间，这种协同效应随酒精浓度增加而增强。本研究为药物辅助犯罪(DFSA)中氯氮平与酒精协同作用的法医学鉴定提供了药动学数据和支持。

Abstract: Objective: To establish an LC-MS/MS method for the determination of clozapine in mouse blood and to investigate the pharmacokinetic interactions between clozapine and different alcoholic beverages (beer, fruit wine, liquor) in mice. Methods: Thirty KM mice were randomly divided into a control group (without alcohol), a beer co-administration group, a fruit wine co-administration group, and a liquor co-administration group. After intragastric administration of clozapine solutions prepared with the respective solvents, blood samples were collected at 12 time points. The samples were pretreated by protein precipitation with acetonitrile and analyzed by LC-MS/MS. Separation was achieved on a Thermo Hypersil GOLD C18 (2.1 mm × 100 mm, 1.9 µm) column with a gradient elution using 0.1% formic acid in water and acetonitrile as mobile phases. Detection was performed using ESI positive ion mode with MRM. Results: The established method showed good linearity (R² = 0.9979), with a limit of detection (LOD) of 0.02 ng/mL and a limit of quantification (LOQ) of 0.1 ng/mL. The pharmacokinetic curves showed that the time to peak concentration (Tmax) of clozapine was approximately 0.5~1 hours. Compared to the control group, all alcohol co-administration groups significantly increased the peak blood concentration (Cmax) of clozapine, with the enhancing effect being more pronounced with higher alcohol concentrations (liquor group > fruit wine group > beer group), alcohol co-administration also delayed the metabolic clearance of clozapine. Behavioral observations showed that alcohol co-administration led to an earlier onset of intoxication symptoms (convulsions, coma) and prolonged the duration of coma. Conclusion: Alcohol can significantly enhance the bioavailability and prolong the duration of action of clozapine, likely through inhibition of metabolic enzymes, and this synergistic effect increases with alcohol concentration. This study provides pharmacokinetic data and support for the forensic identification of clozapine-alcohol synergistic effects in drug-facilitated sexual assault (DFSA) cases.